Upregulation of METTL3 also enhanced the expression of Ki67 in AF127577.4-ORF-increased GBM cells (Fig. 7D), which supported the suppression of AF127577.4-ORF in cell growth via METTL3. Here, MKI67 is linked to glioblastoma.